<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Vascular <z:hpo ids='HP_0000726'>dementia</z:hpo> (VaD) and <z:e sem="disease" ids="C0002395" disease_type="Disease or Syndrome" abbrv="SDAT">Alzheimer's disease</z:e> (AD) are the most common causes of <z:hpo ids='HP_0000726'>dementia</z:hpo> in the elderly </plain></SENT>
<SENT sid="1" pm="."><plain>The aim of this study was to investigate carotid <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo>, serum <z:chebi fb="23" ids="18059">lipid</z:chebi> profiles, and atherogenic hormone levels in nondiabetic Japanese men with VaD or AD </plain></SENT>
<SENT sid="2" pm="."><plain>Carotid artery intima-media thickness (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IMT</z:e>) and plaque, serum <z:chebi fb="23" ids="18059">lipid</z:chebi> and <z:chebi fb="1" ids="6495">lipoprotein</z:chebi> profiles, including <z:chebi fb="2" ids="39026">low-density lipoprotein</z:chebi> (<z:chebi fb="15" ids="39026">LDL</z:chebi>) particle size, as well as insulin-like growth factor-I (IGF-I, somatomedin C) and <z:chebi fb="51" ids="17347">testosterone</z:chebi> levels, were determined in 34 patients with AD, 37 patients with VaD, and 63 healthy male controls </plain></SENT>
<SENT sid="3" pm="."><plain>Age, body mass index, systolic and diastolic blood pressure, and fasting plasma <z:chebi fb="105" ids="17234">glucose</z:chebi>, <z:chebi fb="0" ids="35143">hemoglobin</z:chebi> A(1c) (HbA(1c)), <z:chebi fb="0" ids="17855">triglyceride</z:chebi>, <z:chebi fb="6" ids="39025">high-density lipoprotein</z:chebi> (<z:chebi fb="17" ids="39025">HDL</z:chebi>)-cholesterol, and <z:chebi fb="0" ids="39015">apolipoproteins</z:chebi> (apo) A-I, B, and E levels did not differ significantly among the 3 groups </plain></SENT>
<SENT sid="4" pm="."><plain>However, the mean value of carotid <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IMT</z:e>, the frequency of atherosclerotic plaque deposition, the serum levels of <z:chebi fb="1" ids="47774">LDL-cholesterol</z:chebi>, <z:chebi fb="1" ids="6495">lipoprotein</z:chebi>(a), and <z:chebi fb="23" ids="18059">lipid</z:chebi> <z:chebi fb="39" ids="44785">peroxides</z:chebi>, and the incidence of small dense <z:chebi fb="15" ids="39026">LDL</z:chebi> (particle diameter &lt;/= 25.5 nm) were increased significantly in VaD patients compared with AD patients or controls </plain></SENT>
<SENT sid="5" pm="."><plain>VaD patients had a close reverse correlation between carotid <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IMT</z:e> and <z:chebi fb="15" ids="39026">LDL</z:chebi> particle diameter, which were statistically proven independent risk factors for VaD </plain></SENT>
<SENT sid="6" pm="."><plain>In contrast, AD patients had significantly lower serum levels of IGF-I and <z:chebi fb="51" ids="17347">testosterone</z:chebi> than either VaD patients or controls </plain></SENT>
<SENT sid="7" pm="."><plain>Our results indicate that VaD is associated with atherogenic <z:e sem="disease" ids="C0242339" disease_type="Disease or Syndrome" abbrv="">dyslipidemia</z:e>, in particular, small dense <z:chebi fb="15" ids="39026">LDL</z:chebi> and carotid <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo>, whereas AD is associated with hyposomatomedinemia and <z:hpo ids='HP_0000135'>hypogonadism</z:hpo> rather than <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo> </plain></SENT>
</text></document>